Bosutinib Rowex 500 mg film-coated tablets

Licence status
Authorised: 18/07/2025
Active substances
Bosutinib dihydrate
Dosage Form
Film-coated tablet
Licence number
PA0711/323/003
Licence holder
Rowex Limited,

Product documents

Licence information

ATC code
L01EA04 bosutinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/07/2025

Interchangeable information